BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.
Investors
All regulatory information and reports.
Clinical studies
Discover all the details of our clinical studies.
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
Arsenic Trioxide
An innovative drug to treat autoimmune diseases at the source of the immune cascade.
Our technology
BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.